Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline

This scoping review aims to support a more consistent approach to workforce development in the UK, by identifying and mapping the current evidence base underpinning

Background and Purpose: In 2014, a multidisciplinary breast cancer group developed and disseminated a clinical practice guideline to assist surgeons in choosing eligible patients,

In particular, the tokens of the user-generated content -after some pre-processing of the words, which includes removal of stop-words and non- English words, stemming, and

SHRN aims to: 1) provide health and well-being data from a biennial survey for national, regional and local stakeholders, including schools; 2) co-produce school-based health

Organizational performance may be improved most when performance evaluation practices do include both administrative activities and developmental review sessions and

Patients should understand: • The rationale for deprescribing (associated risks of continued BZRA use, reduced long-term efficacy) • Withdrawal symptoms (insomnia, anxiety) may

Evidence was generated from a Cochrane systematic review of antipsychotic deprescribing trials for the behavioural and psychological symptoms of dementia, and a systematic review was